Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AngioGenex, Inc. | Director, INDEPENDENT DIRECTOR | Stock Option | 850K | Sep 2, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVTA | Invitae Corp | Aug 14, 2023 | 0 | $0 | 3 | Aug 17, 2023 | Interim Chief Financial Officer Exhibit List: Exhibit 24 - Power of Attorney |
ENVB | Enveric Biosciences, Inc. | Sep 9, 2022 | 0 | $0 | 3 | Sep 23, 2022 | Chief Financial Officer |
AIM | AIM ImmunoTech Inc. | Apr 4, 2022 | 0 | $0 | 3 | Apr 4, 2022 | Chief Financial Officer |
AGGX | AngioGenex, Inc. | Dec 31, 2021 | 1 | $32.5K | 5 | Feb 16, 2022 | Director, INDEPENDENT DIRECTOR |